Growth Metrics

Novanta (NOVT) Cash & Equivalents (2016 - 2025)

Novanta (NOVT) has disclosed Cash & Equivalents for 16 consecutive years, with $89.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 3.74% year-over-year to $89.2 million, compared with a TTM value of $89.2 million through Sep 2025, down 3.74%, and an annual FY2024 reading of $114.0 million, up 8.51% over the prior year.
  • Cash & Equivalents was $89.2 million for Q3 2025 at Novanta, down from $109.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $133.9 million in Q3 2021 and bottomed at $76.0 million in Q3 2023.
  • Average Cash & Equivalents over 5 years is $100.5 million, with a median of $100.1 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 54.08% in 2021, then decreased 24.93% in 2022.
  • Year by year, Cash & Equivalents stood at $117.4 million in 2021, then dropped by 14.73% to $100.1 million in 2022, then rose by 4.94% to $105.1 million in 2023, then increased by 8.51% to $114.0 million in 2024, then decreased by 21.73% to $89.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for NOVT at $89.2 million in Q3 2025, $109.9 million in Q2 2025, and $106.0 million in Q1 2025.